Hostname: page-component-7b7567c8c-wxvwp Total loading time: 0 Render date: 2026-11-17T06:19:29.887Z Has data issue: false hasContentIssue false

Transdermal scopolamine for peripheral vertigo (A double-blind study)

Published online by Cambridge University Press:  29 June 2007

T. Rahko*
Affiliation:
Tampere, Finland
P. Karma
Affiliation:
Tampere, Finland
*
Dr. Tapani Rahko, Department of Otolaryngology, Tampere University Central Hospital, SF-33520 Tampere 52, Finland.
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Transdermal scopolamine medication has been evaluated in 30 cases of acute peripheral vertigo. The double blind study revealed favourable effects, e.g. in Menière's disease. The best compromise between effect and side-effects was one active medication patch. The side-effects were those described for scopolamine, such as blurred vision and dryness of the mouth. Transdermal scopolamine seems to offer an alternative form of medication in acute peripheral vertigo.

Information

Type
Research Article
Copyright
Copyright © JLO (1984) Limited 1985